Abstract
Although no new drugs have become available for improved treatment of cerebral edema, the increased understanding of the pathophysiology of the edematous process has led to more rational approaches to therapy, both in patients with cytotoxic intracellular brain edema and those with extracellular vasogenic brain edema. In the unconscious patient, the addition of ICP monitoring is invaluable in helping in the selection of therapy and in measuring the results of therapy.

This publication has 0 references indexed in Scilit: